Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rab 22A Activators

Rab22A Activators refers to a collection of chemical compounds that, either directly or indirectly, are capable of stimulating the activity of the Rab22A protein, a member of the RAS oncogene family. These activators often interact with the complex network of cellular processes and signaling pathways in which Rab22A is involved. While they may not directly bind to and activate Rab22A, they can impact the cellular environment in a way that leads to its activation. This class of compounds is diverse and includes a broad range of molecules, each with unique properties and modes of action. Among the activators, some interact with the endocytic pathway, which Rab22A is known to be involved in.

Other activators can stimulate membrane trafficking events. Some activators exert their effect by disrupting or stabilizing cellular structures that are crucial for Rab22A's role in vesicular trafficking. In addition, many activators are inhibitors of key enzymes or proteins in signaling pathways that impact Rab22A's function. Inhibitors of PI3K, a key player in endocytosis and membrane trafficking pathways, and can indirectly activate Rab22A by stimulating these pathways. A phospholipase C (PLC) inhibitor, could catalyze Rab22A activity by promoting membrane trafficking, while disrupting the Golgi apparatus, potentially igniting Rab22A activity by promoting vesicular trafficking processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA can trigger Protein Kinase C (PKC), which could indirectly initiate RAB22A activity by stimulating membrane trafficking events.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, could indirectly provoke RAB22A activity by stimulating endocytosis and membrane trafficking pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 could indirectly spark RAB22A activity by initiating endocytosis and membrane trafficking pathways.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

By disrupting the Golgi apparatus, Brefeldin A could indirectly ignite RAB22A activity by promoting vesicular trafficking processes.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin, by disrupting endosomal trafficking, could indirectly spur RAB22A activity as it is involved in this process.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Nocodazole, by disrupting microtubules, could indirectly stimulate RAB22A activity by promoting vesicular transport processes.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Paclitaxel could indirectly provoke RAB22A activity by stabilizing microtubules, enhancing vesicular transport processes.

Ciliobrevin D

1370554-01-0sc-507482
10 mg
$413.00
(0)

Ciliobrevin D, a dynein inhibitor, could indirectly spark RAB22A activity by affecting transport along microtubules, a key process in endosomal trafficking.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D could indirectly catalyze RAB22A activity by disrupting actin filaments and thereby promoting vesicle trafficking.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, could potentially indirectly activate RAB22A by promoting vesicle trafficking processes.